Demonstrates lower rates of opioid relapse in men released from jail receiving extended-release naltrexone, highlighting its utility for post-incarceration addiction care.
Extended-release naltrexone is associated with significantly lower rates of opioid relapse among men in the United States following release from jail when compared with a no medication treatment-as-usual condition.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: